Literature DB >> 12107447

Timing of the absence of FMR1 expression in full mutation chorionic villi.

Rob Willemsen1, Carola J M Bontekoe, Lies-Anne Severijnen, Ben A Oostra.   

Abstract

Fragile X syndrome is caused by the expansion of the CGG repeat in the 5' untranslated region of the FMR1 gene. This expansion leads to methylation of the FMR1 promoter region thereby blocking FMR1 protein (FMRP) expression. Prenatal diagnosis can be performed on chorionic villi samples (CVS) by Southern blot analysis. Alternatively, for males, an immunohistochemical method has been introduced for CVS. In this study, we have used this immunocytochemical method for CVS in full mutation male fetuses at different times of gestational age, varying from 10.0-12.5 weeks, and in two cases of full mutation female fetuses (>13 weeks). FMRP expression studies in CVS from full mutation male fetuses (10.0-12.5 weeks) illustrate the timing of the disappearance of FMRP expression in these CVS. Until approximately 10 weeks of gestation, FMRP is expressed normally in full mutation male CVS, whereas FMRP is completely absent at 12.5 weeks of gestation. FMRP expression in full mutation female CVS (>13 weeks) is completely absent in a number of villi, whereas other villi show normal FMRP expression. Unlabelled villi can only be present in the absence of the expression of the full mutation FMR1 gene on one X-chromosome together with the X-inactivation of the normal X allele. FMRP positive villi can be explained by an active normal X allele. The presence of both positive and negative villi indicates that X-inactivation in human CVS is a random process. No villi are found with a mixture of both FMRP-expressing and non-FMRP-expressing cells. This indicates that X-inactivation occurs very early in development, before the villi start to proliferate, and that X-inactivation in villi is a clonal process. In addition, our results indicate that the timing of both X-inactivation and full mutation FMR1 allele inactivation is different, i.e. X-inactivation occurs earlier in development than inactivation of the full mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12107447     DOI: 10.1007/s00439-002-0723-5

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  49 in total

1.  Defining the role of the CGGBP1 protein in FMR1 gene expression.

Authors:  Martina Goracci; Stella Lanni; Giorgia Mancano; Federica Palumbo; Pietro Chiurazzi; Giovanni Neri; Elisabetta Tabolacci
Journal:  Eur J Hum Genet       Date:  2015-08-26       Impact factor: 4.246

Review 2.  Imprinted and X-linked non-coding RNAs as potential regulators of human placental function.

Authors:  Sam Buckberry; Tina Bianco-Miotto; Claire T Roberts
Journal:  Epigenetics       Date:  2013-09-30       Impact factor: 4.528

3.  Postsynaptic FMRP Regulates Synaptogenesis In Vivo in the Developing Cochlear Nucleus.

Authors:  Xiaoyu Wang; Diego A R Zorio; Leslayann Schecterson; Yong Lu; Yuan Wang
Journal:  J Neurosci       Date:  2018-06-27       Impact factor: 6.167

Review 4.  The single active X in human cells: evolutionary tinkering personified.

Authors:  Barbara R Migeon
Journal:  Hum Genet       Date:  2011-06-08       Impact factor: 4.132

Review 5.  New perspectives on the biology of fragile X syndrome.

Authors:  Tao Wang; Steven M Bray; Stephen T Warren
Journal:  Curr Opin Genet Dev       Date:  2012-02-28       Impact factor: 5.578

6.  Differential X reactivation in human placental cells: implications for reversal of X inactivation.

Authors:  Barbara R Migeon; Joyce Axelman; Peter Jeppesen
Journal:  Am J Hum Genet       Date:  2005-07-11       Impact factor: 11.025

7.  Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions.

Authors:  Lillian M Zwemer; Sarah L Nolin; Patricia M Okamoto; Marcia Eisenberg; Heather C Wick; Diana W Bianchi
Journal:  Prenat Diagn       Date:  2016-10-25       Impact factor: 3.050

Review 8.  FMR1: a gene with three faces.

Authors:  Ben A Oostra; Rob Willemsen
Journal:  Biochim Biophys Acta       Date:  2009-02-21

9.  Random X inactivation and extensive mosaicism in human placenta revealed by analysis of allele-specific gene expression along the X chromosome.

Authors:  Joana Carvalho Moreira de Mello; Erica Sara Souza de Araújo; Raquel Stabellini; Ana Maria Fraga; Jorge Estefano Santana de Souza; Denilce R Sumita; Anamaria A Camargo; Lygia V Pereira
Journal:  PLoS One       Date:  2010-06-04       Impact factor: 3.240

10.  Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome.

Authors:  Dilek Colak; Nikica Zaninovic; Michael S Cohen; Zev Rosenwaks; Wang-Yong Yang; Jeannine Gerhardt; Matthew D Disney; Samie R Jaffrey
Journal:  Science       Date:  2014-02-28       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.